Ticker > Company >

Decipher Labs share price

Decipher Labs Ltd.

BSE: 524752 SECTOR: Pharmaceuticals & Drugs  23.03 K   56   6

10.75
0 0
BSE: 05 Sep 04:01 PM

Price Summary

Today's High

₹ 10.99

Today's Low

₹ 10.57

52 Week High

₹ 18.9

52 Week Low

₹ 9.61

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

10.86 Cr.

Enterprise Value

10.83 Cr.

No. of Shares

1.01 Cr.

P/E

0

P/B

1.27

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.45

CASH

0.03 Cr.

DEBT

0 Cr.

Promoter Holding

16.43 %

EPS (TTM)

₹  -0.26

Sales Growth

336%

ROE

0.26 %

ROCE

0.28%

Profit Growth

100.89 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year336%
3 Year53.52%
5 Year-12.23%

Profit Growth

1 Year100.89%
3 Year-37.67%
5 Year-42.69%

ROE%

1 Year0.26%
3 Year-7.4%
5 Year-3.77%

ROCE %

1 Year0.28%
3 Year-7.47%
5 Year-3.79%

Debt/Equity

0

Price to Cash Flow

-365.57

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 16.43 0.00
Mar 2025 16.43 0.00
Dec 2024 16.43 0.00
Sep 2024 16.43 0.00
Jun 2024 16.43 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 53.522500402807% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -219.5455 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 68.7022595107203.

 Limitations

  • The company has shown a poor profit growth of -37.6657196851395% for the Past 3 years.
  • Company has a poor ROE of -7.39672994019016% over the past 3 years.
  • Company has a poor ROCE of -7.47349386834828% over the past 3 years
  • Company has high debtor days of 210.4465.
  • Company has negative cash flow from operations of -0.0297.
  • The company has a low EBITDA margin of 0.881886671646172% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0.38 0.08 0.16 0.23 0.85
Total Expenditure 0.51 0.16 0.25 0.39 0.78
Operating Profit -0.12 -0.07 -0.09 -0.16 0.07
Other Income 0 0.02 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0.01 0.01 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.13 -0.06 -0.09 -0.17 0.06
Tax 0.01 0 0 0 0
Profit After Tax -0.13 -0.06 -0.09 -0.17 0.06
Adjusted EPS (Rs) -0.13 -0.06 -0.09 -0.17 0.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1.42 0.98 0.99 0.81 3.53
Total Expenditure 1.27 0.96 0.63 1.18 3.51
Operating Profit 0.16 0.02 0.36 -0.37 0.02
Other Income 0.01 0.14 0.05 0.03 0.02
Interest 0 0.02 0 0 0
Depreciation 0 0.04 0.05 0.06 0.01
Exceptional Items 0 0 0 -2.24 0
Profit Before Tax 0.17 0.1 0.36 -2.64 0.03
Tax 0 0 0 -0.02 0
Net Profit 0.17 0.1 0.36 -2.62 0.02
Adjusted EPS (Rs.) 0.17 0.1 0.36 -2.59 0.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.1 10.1 10.1 10.1 10.1
Total Reserves 0.97 1.06 1.42 -1.2 -1.17
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 -0.02 -0.02
Current liabilities 0.58 0.23 0.08 0.09 3.83
Total Liabilities 11.65 11.4 11.6 8.97 12.74
Assets
Net Block 0.11 0.26 0.33 0.12 0.1
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 8.41 8.41 8.66 8.66 8.66
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 3.13 2.73 2.6 0.18 3.97
Total Assets 11.65 11.4 11.6 8.97 12.74
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.17 0.1 0.36 -2.64 0.03
Adjustment 0 0 0.06 2.37 0.01
Changes in Assets & Liabilities -0.18 0.18 0.13 0.19 -0.07
Tax Paid 0 0 0 0 0
Operating Cash Flow -0.01 0.27 0.55 -0.08 -0.03
Investing Cash Flow -0.07 -0.19 -0.38 0.09 0
Financing Cash Flow 0.09 -0.09 -0.14 0 0
Net Cash Flow 0.01 -0.01 0.03 0.01 -0.03

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 16.43 16.43 16.43 16.43 16.43
ajjarapu janakiram 16.43 16.43 16.43 16.43 16.43
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 83.57 83.57 83.57 83.57 83.57
cyril sebastian 1.00 1.12 1.19 1.28 1.30
seshu srinivas akula 3.80 3.80 3.80 3.80 3.80
suman chepuri - - 1.02 1.28 1.26
suriadoss elumalai 1.42 1.42 1.42 1.42 1.42
sushant mohan lal 2.14 2.14 2.14 2.14 2.14
shri krishna maheshwari(h... - - - 1.22 -

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Decipher Labs - Quaterly Results 14 Aug, 6:39 PM Decipher Labs - Quaterly Results 14 Aug, 6:39 PM Decipher Labs informs about board meeting 11 Aug, 2:25 PM Decipher Labs - Quaterly Results 13 Feb, 7:04 PM Decipher Labs - Quaterly Results 14 Aug, 2:56 PM Decipher Labs - Quaterly Results 14 Aug, 2:56 PM Decipher Labs informs about typographical error in financial results 7 Jun, 5:31 PM Decipher Labs informs about loss of share certificate 20 Feb, 12:24 PM Decipher Labs - Quaterly Results 14 Feb, 7:07 PM Decipher Labs informs about trading window closure 30 Dec, 1:25 PM Decipher Labs informs about book closure and cut-off date 8 Sep, 4:45 PM Decipher Labs informs about newspaper clippings 16 Feb, 12:35 PM Decipher Labs informs about closure of trading window 27 Dec, 4:32 PM Decipher Labs informs about disclosure 16 Sep, 3:30 PM Decipher Labs - Quaterly Results 16 May, 9:53 PM Decipher Labs - Quaterly Results 16 May, 9:53 PM Decipher Labs informs about disclosure 5 Apr, 2:35 PM Decipher Labs informs about disclosure 17 Mar, 5:23 PM Decipher Labs informs about disclosure 14 Mar, 9:09 AM Decipher Labs informs about compliance certificate 5 Jan, 1:18 PM Decipher Labs informs about disclosures 31 Dec, 11:30 AM Decipher Labs informs about updates 17 Dec, 12:57 PM Decipher Labs informs about disclosure 16 Dec, 9:31 AM Decipher Labs informs about disclosure 14 Dec, 11:29 AM Decipher Labs opens branch office in Indore 1 Dec, 3:08 PM Decipher Labs informs about business updates 1 Dec, 2:40 PM Decipher Labs looking to foray into AI, Virtual Reality and Augmented Reality Space 1 Dec, 2:05 PM Decipher Labs informs about annual report 3 Sep, 4:08 PM Decipher Labs gets approval for incorporation of subsidiary company 1 Jan, 12:28 PM Decipher Labs considering business expansion of portfolio to cater to retail sales of medicines 24 Dec, 12:24 PM Decipher Labs informs about compliance certificate 12 Oct, 2:13 PM Decipher Labs informs about outcome of board meeting 3 Sep, 10:36 AM Decipher Labs informs about compliance certificate 3 Jul, 3:14 PM Decipher Labs informs about board meeting 19 Jun, 4:31 PM

Decipher Labs Stock Price Analysis and Quick Research Report. Is Decipher Labs an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Decipher Labs. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Decipher Labs has a PE ratio of -41.7637917637918 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Decipher Labs has ROA of 0.2146% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Decipher Labs has a Current ratio of 1.036.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Decipher Labs has a ROE of 0.2613%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Decipher Labs has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Decipher Labs has reported revenue growth of 336% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Decipher Labs for the current financial year is 0.557820817759663%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Decipher Labs is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Decipher Labs is Rs -0.2574. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Decipher Labs in Ticker for free. Also, one can get the intrinsic value of Decipher Labs by using Valuation Calculators, which are available with a Finology ONE subscription. 

Decipher Labs FAQs

Q1. What is Decipher Labs share price today?
Ans: The current share price of Decipher Labs is Rs 10.75.

Q2. What is the market capitalisation of Decipher Labs?
Ans: Decipher Labs has a market capitalisation of Rs 10.8575 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Decipher Labs?
Ans: The PE ratio of Decipher Labs is -41.7637917637918 and the P/B ratio of Decipher Labs is 1.27172279991956, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Decipher Labs share?
Ans: The 52-week high share price of Decipher Labs is Rs 18.9, and the 52-week low share price of Decipher Labs is Rs 9.61.

Q5. Does Decipher Labs pay dividends?
Ans: Currently, Decipher Labs does not pay dividends. Dividend yield of Decipher Labs is around 0%.

Q6. What are the face value and book value of Decipher Labs shares?
Ans: The face value of Decipher Labs shares is Rs 10, while the book value per share of Decipher Labs is around Rs 8.4531. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Decipher Labs?
Ans: Decipher Labs has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Decipher Labs?
Ans: The ROE of Decipher Labs is 0.2613% and ROCE of Decipher Labs is 0.2815%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Decipher Labs a good buy for the long term?
Ans: The Decipher Labs long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Decipher Labs undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Decipher Labs appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Decipher Labs’s financials?
Ans: You can review Decipher Labs’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Decipher Labs
X